Pure Global AI
NCT06035965Not yet recruiting

Comparison of Quality of Life and Changes Experienced by Patients After Epilepsy Surgery

Comparison of Quality of Life and Changes Experienced by Patients After Epilepsy Surgery, With Long-term Epileptological Objective Results
University Hospital, ToulouseClinicalTrials.govother
Study focus
Disease/Condition
Epilepsy
Drug/Device/Intervention
Epilepsy Surgery Satisfaction Questionnaire (ESSQ-19)
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
University Hospital, Toulouse
Location
Toulouse, France
Timeline & enrollment
Phase
N/A
Start date
Dec 01, 2023
End date
Dec 01, 2024
Enrollment
160 participants
Primary outcome

Evaluation of the changes felt by patients

Summary

Epilepsy is one of the most common chronic neurological diseases. According to data from the
 World Health Organization (WHO), it affects 0.5 to 1% of the population, or around 70 million
 people world-wide and around 600,000 in France. There are several more or less severe forms
 of epilepsy depending on the type of epileptic seizures and the frequency of these seizures.
 About 30% of epileptic patients respond poorly to well-conducted medical treatment, which
 makes the number of so-called drug-resistant patients estimated at between 100,000 and
 150,000 patients.
 
 Epilepsy surgery is possible in some cases of drug-resistant epilepsy and can lead to
 complete seizure control. Beyond the impact on the control of seizures, surgery can have an
 impact on the lives of patients at the psychological, emotional and cognitive level, with
 consequences on their socio-professional but also personal life. Thus the impact on the daily
 life of patients after epilepsy surgery can vary greatly from one patient to another and the
 personal feelings of operated patients do not always seem to correspond to the objective
 elements collected by doctors. 2.3 The investigators want to retrospectively assess the
 satisfaction and quality of life of patients operated on for more than 2 years based on their
 epileptological results (frequency of seizures).

ICD-10 classifications
EpilepsyEpilepsy, unspecifiedOther epilepsyStatus epilepticusOther status epilepticus
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06035965
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06035965 through Pure Global AI's free database. This phase not specified trial is sponsored by University Hospital, Toulouse and is currently Not yet recruiting. The study focuses on Epilepsy. Target enrollment is 160 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.